Pay in 4 interest-free payments of $5.83 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Pigment is one path, but it is not the only one
Both options support different budgets and organizational priorities to reduce GLP-1 medication costs and lower overall healthcare expenditures
Currently, the FDA has officially approved a higher-dose formulation of semaglutide called Wegovy specifically for chronic weight management in adults who are overweight or obese, even if they do not have diabetes
The approval is backed by data from the pivotal Phase III PERSEUS study, where treatment with subcutaneous Darzalex Faspro reduced the risk of disease progression or death by 60% in the intended patient population compared to standard of care
The dual action means Tirzepatide not only reduces appetite but might also have an additional effect on how the body handles blood sugar and stores fat
US$ 22.28
US$ 27.65
US$ 23.19
US$ 29.43
US$ 26.81
US$ 23.48
